Suppr超能文献

与皮质类固醇注射相关的足底筋膜破裂并发症。

Complications of plantar fascia rupture associated with corticosteroid injection.

作者信息

Acevedo J I, Beskin J L

机构信息

Georgia Baptist Medical Center, Atlanta, USA.

出版信息

Foot Ankle Int. 1998 Feb;19(2):91-7. doi: 10.1177/107110079801900207.

Abstract

From 1992 to 1995, 765 patients with a clinical diagnosis of plantar fasciitis were evaluated by one of the authors. Fifty-one patients were diagnosed with plantar fascia rupture, and 44 of these ruptures were associated with corticosteroid injection. The authors injected 122 of the 765 patients, resulting in 12 of the 44 plantar fascia ruptures. Subjective and objective evaluations were conducted through chart and radiographic review. Thirty-nine of these patients were evaluated at an average 27-month follow-up. Thirty patients (68%) reported a sudden onset of tearing at the heel, and 14 (32%) had a gradual onset of symptoms. In most cases the original heel pain was relieved by rupture. However, these patients subsequently developed new problems including longitudinal arch strain, lateral and dorsal midfoot strain, lateral plantar nerve dysfunction, stress fracture, hammertoe deformity, swelling, and/or antalgia. All patients exhibited diminished tension of the plantar fascia upon examination by the stretch test. Comparison of calcaneal pitch angles in the affected and uninvolved foot showed a statistically significant difference of 3.7 degrees (P = 0.0001). Treatment included NSAIDs, rest or cross-training, stretching, orthotics, and boot-brace immobilization. At an average 27-month follow-up, 50% had good/excellent scores and 50% had fair/poor scores. Recovery time was varied. Ten feet were asymptomatic by 6 months post rupture, four feet by 12 months post rupture, and 26 feet remained symptomatic 1 year post rupture. Our findings demonstrate that plantar fascia rupture after corticosteroid injection may result in long-term sequelae that are difficult to resolve.

摘要

1992年至1995年期间,其中一位作者对765例临床诊断为足底筋膜炎的患者进行了评估。51例患者被诊断为足底筋膜破裂,其中44例破裂与皮质类固醇注射有关。作者对765例患者中的122例进行了注射,导致44例足底筋膜破裂中的12例。通过病历和影像学检查进行主观和客观评估。其中39例患者接受了平均27个月的随访。30例患者(68%)报告足跟处突然出现撕裂感,14例患者(32%)症状逐渐出现。在大多数情况下,最初的足跟疼痛因破裂而缓解。然而,这些患者随后出现了新的问题,包括纵弓劳损、足中外侧和背侧劳损、足底外侧神经功能障碍、应力性骨折、槌状趾畸形、肿胀和/或疼痛性步态。所有患者在拉伸试验检查时均表现出足底筋膜张力降低。患侧与未患侧足的跟骨倾斜角比较显示,差异有统计学意义,为3.7度(P = 0.0001)。治疗方法包括使用非甾体抗炎药、休息或交叉训练、拉伸、矫形器以及靴式支具固定。在平均27个月的随访中,50%的患者评分良好/优秀,50%的患者评分一般/较差。恢复时间各不相同。破裂后6个月时,10只足无症状;12个月时,4只足无症状;破裂1年后,26只足仍有症状。我们的研究结果表明,皮质类固醇注射后足底筋膜破裂可能导致难以解决的长期后遗症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验